Soros Fund Management LLC reduced its position in Aetna Inc (NYSE:AET) by 6.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 512,928 shares of the company’s stock after selling 32,657 shares during the quarter. Aetna accounts for about 1.5% of Soros Fund Management LLC’s holdings, making the stock its 10th largest holding. Soros Fund Management LLC owned approximately 0.16% of Aetna worth $94,122,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Sio Capital Management LLC boosted its holdings in Aetna by 23.7% during the 2nd quarter. Sio Capital Management LLC now owns 39,135 shares of the company’s stock valued at $7,181,000 after acquiring an additional 7,500 shares during the period. Zurich Insurance Group Ltd FI boosted its holdings in Aetna by 82.2% during the 2nd quarter. Zurich Insurance Group Ltd FI now owns 78,959 shares of the company’s stock valued at $14,489,000 after acquiring an additional 35,616 shares during the period. Omni Partners LLP boosted its holdings in Aetna by 26.3% during the 2nd quarter. Omni Partners LLP now owns 766,117 shares of the company’s stock valued at $140,582,000 after acquiring an additional 159,483 shares during the period. Colony Group LLC boosted its holdings in Aetna by 349.8% during the 2nd quarter. Colony Group LLC now owns 8,569 shares of the company’s stock valued at $1,572,000 after acquiring an additional 6,664 shares during the period. Finally, Canyon Capital Advisors LLC boosted its holdings in Aetna by 29.9% during the 2nd quarter. Canyon Capital Advisors LLC now owns 811,651 shares of the company’s stock valued at $148,938,000 after acquiring an additional 186,651 shares during the period. Hedge funds and other institutional investors own 83.51% of the company’s stock.

NYSE AET opened at $203.57 on Thursday. Aetna Inc has a fifty-two week low of $149.69 and a fifty-two week high of $203.74. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.74 and a quick ratio of 0.74. The company has a market capitalization of $66.20 billion, a price-to-earnings ratio of 20.65, a price-to-earnings-growth ratio of 1.73 and a beta of 0.68.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, topping the consensus estimate of $3.04 by $0.39. Aetna had a return on equity of 20.66% and a net margin of 5.77%. The business had revenue of $15.56 billion during the quarter, compared to analysts’ expectations of $15.59 billion. During the same quarter last year, the business posted $3.42 EPS. The business’s revenue was up .2% on a year-over-year basis. research analysts expect that Aetna Inc will post 11.31 earnings per share for the current year.

Several brokerages recently weighed in on AET. Cantor Fitzgerald cut Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 target price for the company. in a report on Wednesday, August 22nd. ValuEngine cut Aetna from a “buy” rating to a “hold” rating in a report on Friday, June 1st. Finally, Zacks Investment Research upgraded Aetna from a “sell” rating to a “hold” rating in a report on Monday, August 6th. Eight analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Aetna currently has an average rating of “Hold” and a consensus price target of $200.38.

About Aetna

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Recommended Story: Google Finance Portfolio Tips and Tricks

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.